<p>Cancer of unknown primary (CUP), a&#xa0;rare metastatic malignancy for which a&#xa0;primary site cannot be established after the diagnostic workup, has an unfavorable prognosis. Histopathological assessment, including comprehensive panels of immunohistochemistry (IHC) of biopsy specimens, remains the mainstay for establishing a&#xa0;diagnosis, identifying a&#xa0;putative tissue of origin (ToO), and guiding therapy decisions. Combining IHC and complex molecular analyses may identify therapy targets to improve patient outcomes. This review focuses on the standard-of-care diagnostic workup of suspected CUP samples, the pathologist’s role in the search for therapy targets, and current as well as future developments in the field.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Diagnostic approaches to cancer of unknown primary—the pathologist’s perspective

  • Michael Guenther,
  • Andrea Brunner-Véber,
  • Steffen Ormanns

摘要

Cancer of unknown primary (CUP), a rare metastatic malignancy for which a primary site cannot be established after the diagnostic workup, has an unfavorable prognosis. Histopathological assessment, including comprehensive panels of immunohistochemistry (IHC) of biopsy specimens, remains the mainstay for establishing a diagnosis, identifying a putative tissue of origin (ToO), and guiding therapy decisions. Combining IHC and complex molecular analyses may identify therapy targets to improve patient outcomes. This review focuses on the standard-of-care diagnostic workup of suspected CUP samples, the pathologist’s role in the search for therapy targets, and current as well as future developments in the field.